Sidney Wolfe, a doctor at Health Research Group, explains at a National Academies seminar that the Food and Drug Administration has eased regulation of direct-to-consumer prescription advertisements.

Posted by Staff on August 3, 2005 |

Wolfe says since 1997, after revising regulatory procedures for drug ads, the FDA cited fewer violations by drug companies despite an increase in prescription advertising. Wolfe reasons that since the quality of the ads has not changed since then, there should also have been a rise in number of citations. (:49)

 
icon for podpress  Standard Podcast: Play Now | Play in Popup | Download

August 3, 2005

Comments are closed.


Latest Audio

  • Labor Secretary Recalls Helping Undocumented Students Go To College
  • GOP Leaders Look To Suade Moderate Democrats On Health Care Vote
  • Democrats’ Health Bill One Great Big Ponzi Scheme, Says Thune
  • Senate Democrats Employ ‘Gimmickry’ To Keep Health Bill Below $900 Billion

Happening Now - TRNS on Twitter